Carmustine

Name
Carmustine
Alternate Names
BiCNU
Carmustinea
DTI 015
DTI-015
DTI015
WR 139021
WR-139021
WR139021
Abbreviations
BCNU
Category
Chemotherapy
Subcategory
NSC Number
409962
Primary Site
Brain
Hodgkin Lymphoma
Kidney cancer
Multiple myeloma
Non-Hodgkin lymphoma
Histology
None
Remarks
Phase I FDA approved uses on brain tumor, Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma. Guilford Pharmaceuticals.(nitrosourea) (alkylating agent)
Coding
This drug should be coded